Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

naroparcil

Known as: (4-(4-cyanobenzoyl)phenyl)-1,5-dithio-beta-D-xylopyranoside 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The antithrombotic beta-D-xyloside, naroparcil, has previously been shown to induce a dose-related increase of circulating… Expand
Is this relevant?
1995
1995
Beta-D-Xylosides are known to initiate or prime free glycosaminoglycan (GAG) chain synthesis in cell and tissue culture. As such… Expand
Is this relevant?
1995
1995
4-Methylumbelliferyl beta-D-xylosides (beta-D-xylosides) inhibit proteoglycan synthesis, and this is associated with reduced… Expand
Is this relevant?
1995
1995
Inhibition of proteoglycan (P) synthesis by β-D xylosides (Xyl) is associated with growth inhibition in several cultured vascular… Expand
Is this relevant?
1994
1994
The venous antithrombotic profile of naroparcil or (4-[4-cyanobenzoyl]-phenyl)-1.5-dithio-beta-D-xylopyranoside was investigated… Expand
Is this relevant?